Boyd Taylor bought AVTX
October 1, 2025 · Form 4 insider transaction
Boyd Taylor bought 275,000 shares of Avalo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
275,000
Price
$0.00
Total value
N/A
InsiderBoyd Taylor
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 6, 2025
Shares owned after275,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option was granted on October 1, 2025, and vests over four years, with the first 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following three years, subject to the reporting person's continued employment with the Company on each applicable vesting date.